MEDLINE Journals

    The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.

    Authors
    Shalhub S, Parsee A, Gallagher SF, et al. 
    Institution

    Department of Surgery and Interdisciplinary Obesity Study Group, University of South Florida Health Sciences Center, Tampa, FL 33601, USA.

    Source
    Obes Surg 2004 Jan; 14(1) :54-9.
    Abstract

    Nonalcoholic Steatohepatitis (NASH) commonly occurs in obese patients and predisposes to cirrhosis. Prevalence of NASH in bariatric patients is unknown. Our aim was to determine the role of routine liver biopsy in managing bariatric patients.Prospective data on patients undergoing Roux-en-Y gastric bypass (RYGBP) was analyzed. One pathologist graded all liver biopsies as mild, moderate or severe steatohepatitis. NASH was defined as steatohepatitis without alcoholic or viral hepatitis. Consecutive liver biopsies were compared to those liver biopsies selected because of grossly fatty livers.242 patients underwent open and laparoscopic RYGBP from 1998-2001. Routine liver biopsies (68 consecutive patients) and selective liver biopsies (additional 86/174, 49%) were obtained. Findings of cirrhosis on frozen section changed the operation from a distal to a proximal RYGBP. The two groups were similar in age, gender, and BMI. The group with the routine liver biopsies showed a statistically significant larger preponderance of NASH (37% vs 32%). Both groups had a similar prevalence of cirrhosis. Neither BMI nor liver enzymes predicted the presence or severity of NASH.Routine liver biopsy documented significant liver abnormalities in a larger group of patients compared with selective liver biopsies, thereby suggesting that liver appearance is not predictive of NASH. Liver biopsy remains the gold-standard for diagnosing NASH. We recommend routine liver biopsy during bariatric operations to determine the prevalence and natural history of NASH, which will have important implications in directing future therapeutics for obese patients with NASH and for patients undergoing bariatric procedures.

    Mesh
    Adult
    Biopsy
    Body Mass Index
    Fatty Liver
    Female
    Gastric Bypass
    Humans
    Liver Function Tests
    Male
    Middle Aged
    Obesity, Morbid
    Preoperative Care
    Prospective Studies
    Severity of Illness Index
    Language

    eng

    Pub Type(s)
    Journal Article
    PubMed ID

    14980034

    Content Manager
    Related Content

    Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?

    Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings.

    [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].

    Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

    Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.

    Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery.

    Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.

    Diagnostic value of ultrasonographic examination for nonalcoholic steatohepatitis in morbidly obese patients undergoing laparoscopic bariatric surgery.